Orion Biotechnology Presented at the 3rd GPCR-Targeted Drug Discovery Summit in Boston
Ottawa, Canada, March 06, 2024 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd. (Orion), a drug discovery and development company unlocking the therapeutic potential of previously undruggable G Protein-Coupled Receptors (GPCRs), today announced that it will